Bros. Advisors Lp Baker Sells 732,827 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONC) Director Bros. Advisors Lp Baker sold 732,827 shares of Beigene stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $260.00, for a total transaction of $190,535,020.00. Following the completion of the sale, the director now owns 730,642 shares in the company, valued at approximately $189,966,920. This represents a 50.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Beigene Trading Down 2.4 %

NASDAQ ONC opened at $271.80 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93. Beigene, Ltd. has a 12 month low of $126.97 and a 12 month high of $287.88. The company has a market capitalization of $26.60 billion, a P/E ratio of -32.99, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63.

Beigene (NASDAQ:ONC) last released its earnings results on Thursday, February 27th. The company reported ($1.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.55). Beigene had a negative return on equity of 25.12% and a negative net margin of 25.94%. The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.09 billion. On average, sell-side analysts anticipate that Beigene, Ltd. will post -5.82 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Macquarie boosted their price target on shares of Beigene from $259.00 to $313.00 and gave the stock an “outperform” rating in a research report on Friday.

About Beigene

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.